Scarica l'app Stockscreener
8.04
8.94%
0.66
Dopo l'orario di chiusura:
7.90
-0.14
-1.74%
Precedente Chiudi:
$7.38
Aprire:
$7.42
Volume 24 ore:
91,397
Relative Volume:
0.05
Capitalizzazione di mercato:
$4.30M
Reddito:
$1.75M
Utile/perdita netta:
$-5.68M
Rapporto P/E:
-1.65
EPS:
-4.8726
Flusso di cassa netto:
-
1 W Prestazione:
+16.35%
1M Prestazione:
+2,553%
6M Prestazione:
+1,242%
1 anno Prestazione:
+1,035%
Intervallo 1D:
$7.40
$8.50
Intervallo di 1 settimana:
$6.86
$8.50
Portata 52W:
$0.197
$8.50
Scisparc Ltd Stock (SPRC) Company Profile
Confronta SPRC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
8.04 | 3.69M | 1.75M | -5.68M | 0 | -4.8726 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Scisparc Ltd Borsa (SPRC) Ultime notizie
how scisparc ltd. stock performs during market volatility3x Growth Potential - Newser
Why SciSparc Ltd. stock attracts strong analyst attentionMarket Beating Strategy - Newser
What makes SciSparc Ltd. stock price move sharplyTrend Based Entry Alerts - Newser
How SciSparc Ltd. stock performs during market volatilityLow Risk Profit Ideas - Newser
SciSparc (NASDAQ:SPRC) Trading Up 10.2% – What’s Next? - Defense World
IM Cannabis Strengthens Leadership: Lands $1M Strategic Funding and Cannabis Industry Veteran Director - Stock Titan
SciSparc Announces Expanding its Clinical Operations to Include a U.S. Site Towards its Phase IIb Trial with its Proprietary SCI-110 for the Treatment of Tourette Syndrome - Barchart.com
SciSparc Announces Reverse Share Split Effective July 3, 2025 - TipRanks
SciSparc Stock Set to Reverse Split on Thursday, July 3rd (NASDAQ:SPRC) - Defense World
SciSparc Ltd. Shareholders Approve Key Proposals at Annual Meeting - TipRanks
SciSparc to implement 1-for-21 reverse share split on July 3 - Investing.com India
SciSparc announces 1-for-21 reverse stock split - TipRanks
SciSparc to Implement 1-for-21 Reverse Stock Split - MarketScreener
SciSparc Ltd. Advances Merger with AutoMax Motors - TipRanks
SciSparc announces publication of Japanese patent application - MSN
Therapix Biosciences Ltd. Announces Executive Changes - marketscreener.com
SciSparc Unveils Japanese Patent for Novel Pain Relief Combination - TipRanks
SciSparc secures Japanese patent for pain relief combo By Investing.com - Investing.com South Africa
SciSparc Ltd. Announces Publication of Japanese Patent Application - marketscreener.com
SciSparc secures Japanese patent for pain relief combo - Investing.com
SciSparc Ltd. Announces Publication of Novel Japanese Patent for Enhanced Pain Management Therapy Combining Paracetamol and PEA - Nasdaq
SciSparc Announces Publication of Japanese Patent Application - GlobeNewswire
SciSparc's New Pain Relief Patent Could Make Paracetamol Safer for Millions - Stock Titan
SciSparc sets annual shareholder meeting for June 25 By Investing.com - Investing.com Nigeria
SciSparc sets annual shareholder meeting for June 25 - Investing.com Australia
SciSparc Ltd. Announces Annual General Meeting for June 2025 - TipRanks
SciSparc and Clearmind Secure European Patent for Cocaine Addiction Therapy - TipRanks
SciSparc Ltd. Announces European Patent Application for Cocaine Addiction Treatment in Collaboration with Clearmind Medicine Inc. - Nasdaq
SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire
SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction - Stock Titan
About Us - FinancialContent
Aegis Capital Corp. acted as Exclusive Placement Agent on a $5.0 Million Private Placement for SciSparc Ltd. (NASDAQ: SPRC) - The Globe and Mail
SciSparc Ltd: Weathering Stock Market Storms with 3.17M Market Cap - investchronicle.com
A review of SPRC’s current quarter earnings predictions - uspostnews.com
What's Going On With jeffs' Brands Today? - Benzinga
Jeffs' Brands to Sell Smart Repair Pro Unit, SciSparc Nutraceuticals Stake to Plantify Foods; Shares Jump - marketscreener.com
Jeffs' Brands Strategic Pivot: $11.8M Asset Sale Transforms into 90% Stake in Canadian Company - Stock Titan
SciSparc and Clearmind file patent for eating disorder treatment - Investing.com
SciSparc and Clearmind file patent for eating disorder treatment By Investing.com - Investing.com India
SciSparc announces collaboration with Clearmind Medicine - TipRanks
SciSparc and Clearmind File Patent for Eating Disorder Treatment - TipRanks
SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders - The Manila Times
SciSparc-Clearmind Collaboration Leads to Filing of - GlobeNewswire
Novel Eating Disorder Treatment Patent Filed for 70M Patient Market | SPRC Stock News - Stock Titan
3 Reasons OMI is Risky and 1 Stock to Buy Instead - The Globe and Mail
Thinking Of Selling SciSparc Ltd (NASDAQ: SPRC) Stock? Check This Out First - Stocksregister
SciSparc (NASDAQ:SPRC) Shares Down 6% – Here’s Why - Defense World
SciSparc Extends Deadline for Miza III Ventures Deal - TipRanks
SciSparc Ltd. Extends Merger Agreement with AutoMax Motors - TipRanks
SciSparc Ltd. (NASDAQ:SPRC) Short Interest Up 1,435.0% in March - Defense World
Scisparc Ltd Azioni (SPRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):